LOS ANGELES, CA — DaVita Inc. (“DaVita”), a provider of dialysis services for patients suffering from chronic kidney failure, has acquired certain assets, including five dialysis centers from Kidney Center, Inc (“KCI” or the “Company”). FocalPoint Securities, LLC (“FocalPoint”) served as exclusive financial advisor to KCI.
KCI is one of California’s leading providers of dialysis services for patients experiencing kidney failure. The Company provides dialysis services to over 1,150 patients through 13 outpatient dialysis centers located in Southern and Central California. KCI also provides inpatient dialysis services to 14 hospitals and nursing homes, conducts clinical trials and nursing education services.
DaVita provides administrative services to 1,530 outpatient dialysis centers located in 43 states and the District of Columbia, serving approximately 118,000 patients, as well as provides acute inpatient dialysis services in approximately 720 hospitals. The acquisition of KCI’s dialysis centers expands its presence in California.
Rajesh Sood, Managing Director at FocalPoint, commented, “Dr. Ushakant Thakkar and the entire management team at KCI have dedicated themselves to improving the lives of patients with end stage renal disease. We are fortunate to have worked with such dedicated individuals to achieve a successful outcome on this initial transaction.”
About Kidney Center, Inc.
KCI is one of California’s leading providers of dialysis services for patients with end stage renal disease (“ESRD”), or kidney failure. The Company provides dialysis services to over 1,150 patients through 13 outpatient dialysis centers in Ventura County, West San Fernando Valley, West Los Angeles and San Luis Obispo County in California. In addition to operating outpatient dialysis centers, KCI provides inpatient dialysis services to 14 hospitals and nursing homes on a contract basis through its wholly-owned subsidiary, Dialysis Stat Medical Group, Inc. KCI also conducts clinical trials as well as provides nursing education services. For more information, please visit www.kidneycenter.com.
About DaVita Inc.
DaVita Inc., a publicly traded $6.4 billion market cap company, provides dialysis services for patients suffering from chronic kidney failure, which is known as end stage renal disease (ESRD) in the United States. The company operates kidney dialysis centers, and provides related medical services primarily in dialysis centers and in contracted hospitals. Its services include outpatient dialysis services; hospital inpatient hemodialysis services; and ESRD laboratory services. The company also offers infusion therapy services; DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; vascular access services; disease management services and special needs plans; physician services; and clinical research programs. For more information, please visitwww.davita.com.
About FocalPoint Securities, LLC
FocalPoint is an independent investment bank, specializing in mergers and acquisitions, private placements (both debt and equity), financial restructurings and distressed transactions. The firm’s primary focus is on middle-market companies. For more information, please visit www.focalpointllc.com.
Please contact Rajesh Sood at 310-405-7050 firstname.lastname@example.org with any questions about this transaction.